Deciphering the Innate Lymphoid Cell Transcriptional Program  by Seillet, Cyril et al.
ArticleDeciphering the Innate Lymphoid Cell
Transcriptional ProgramGraphical AbstractHighlightsd ILCp transcriptomics define the blueprint for hierarchical ILC
development
d PD-1 identifies the PLZF-expressing ILC precursor in the
bone marrow
d Transient NFIL3 expression prior to ID2 expression is
required for ILC development
d ID2 and TCF-1 are required to extinguish stem cell and B and
T cell gene programsSeillet et al., 2016, Cell Reports 17, 436–447
October 4, 2016 ª 2016 The Author(s).
http://dx.doi.org/10.1016/j.celrep.2016.09.025Authors
Cyril Seillet, Lisa A. Mielke,
Daniela B. Amann-Zalcenstein, ...,
Nicholas D. Huntington,
Sebastian Carotta, Gabrielle T. Belz
Correspondence
seillet@wehi.edu.au (C.S.),
sebastian.carotta@
boehringer-ingelheim.com (S.C.),
belz@wehi.edu.au (G.T.B.)
In Brief
Seillet et al. define the hierarchical
blueprint for ILC development using
global transcriptomic analyses of ILC
progenitors. This revealed that PD-1 is a
key marker of ILCp and uncovered a
regulatory circuit governed by NFIL3 in
regulating ID2 and TCF-1 essential for ILC
differentiation.Accession NumbersGSE75851
Cell Reports
ArticleDeciphering the Innate Lymphoid
Cell Transcriptional Program
Cyril Seillet,1,2,* Lisa A. Mielke,1,2 Daniela B. Amann-Zalcenstein,1,2 Shian Su,1,2 Jerry Gao,1,2 Francisca F. Almeida,1,2
Wei Shi,1,2,3 Matthew E. Ritchie,1,2 Shalin H. Naik,1,2 Nicholas D. Huntington,1,2 Sebastian Carotta,1,4,*
and Gabrielle T. Belz1,2,5,*
1The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Parkville, VIC 3052,
Australia
2Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia
3Department of Computing and Information Systems, University of Melbourne, Parkville, VIC 3010, Australia
4Boehringer-Ingelheim RCV, Doktor-Boehringer-Gasse 5–11, 1120 Vienna, Austria
5Lead Contact
*Correspondence: seillet@wehi.edu.au (C.S.), sebastian.carotta@boehringer-ingelheim.com (S.C.), belz@wehi.edu.au (G.T.B.)
http://dx.doi.org/10.1016/j.celrep.2016.09.025SUMMARY
Innate lymphoid cells (ILCs) are enriched at mucosal
surfaces, where they provide immune surveillance.
All ILC subsets develop from a common progenitor
that gives rise to pre-committed progenitors for
each of the ILC lineages. Currently, the temporal con-
trol of gene expression that guides the emergence
of these progenitors is poorly understood. We used
global transcriptional mapping to analyze gene
expression in different ILC progenitors. We identified
PD-1 to be specifically expressed in PLZF+ ILCp and
revealed that the timing and order of expression of
the transcription factors NFIL3, ID2, and TCF-1 was
critical. Importantly, induction of ILC lineage commit-
ment required only transient expression of NFIL3
prior to ID2 and TCF-1 expression. These findings
highlight the importance of the temporal program
that permits commitment of progenitors to the ILC
lineage, and they expand our understanding of the
core transcriptional program by identifying potential
regulators of ILC development.INTRODUCTION
Innate lymphoid cells (ILCs) are enriched at mucosal surfaces
and sense inflammatory signals to provide protection from me-
chanical and pathogenic insults through rapid secretion of cyto-
kines. They develop initially from progenitors in the fetal liver
(Chea et al., 2016; Ishizuka et al., 2016) and, later, in the adult
bone marrow (BM) (Constantinides et al., 2014; Klose et al.,
2014; Yu et al., 2014). Subsequently, ILCs seedmucosal tissues,
where they become tissue-resident and continue to proliferate in
these tissues to maintain tissue homeostasis. Self-renewal in the
localized environment is generally sufficient to deal with acute
physiological stressors and infection, but long-term protection436 Cell Reports 17, 436–447, October 4, 2016 ª 2016 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://requires recruitment of bone marrow-derived progenitors to fully
replenish the pool of tissue-resident ILCs.
All ILCs depend on the transcription factors inhibitor of DNA
binding 2 (ID2, encoded by Idb2) and nuclear factor interleukin
3 (NFIL3) because the deletion of either factor in early lymphoid
progenitors severely impairs the development of all ILC subsets.
ID2 modulates signaling by heterodimerization with E proteins to
prevent initiation of transcription. Constitutive expression of Id2
is subsequently required to maintain ILC3s and ILC1/natural
killer (NK) cell homeostasis (Delconte et al., 2016; Guo et al.,
2014). In contrast, NFIL3 is essential for the formation of ILC pro-
genitors downstream of the common lymphoid progenitor (CLP)
(Seillet et al., 2014a, 2014b) but appears to be dispensable in
mature NK cells (Firth et al., 2013). The exact functional relation-
ship between NFIL3 and ID2 is currently incompletely under-
stood. Although it has been proposed that NFIL3 is needed to
directly activate ID2 (Male et al., 2014; Xu et al., 2015), ID2
expression is not altered in NFIL3-deficient NK cells (Crotta
et al., 2014; Seillet et al., 2014a). TCF-1 (T cell factor 1, encoded
by Tcf7) has also been shown to be necessary for the ILC differ-
entiation, and its loss affects the differentiation of multiple ILC
subsets (Mielke et al., 2013; Yang et al., 2013). The interactions
among TCF-1, NFIL3, and ID2 are likely to form a critical decision
hub for the differentiation of the earliest bone marrow progenitor
cells that give rise to the ILC lineage. Despite this, exactly how
the molecular cues of each of these factors are integrated and
drive commitment remains unclear.
Here, we utilized a highly purified ILC progenitor called the
a-lymphoid precursor (aLP) (Yu et al., 2014) immediately down-
stream of the CLP to track the transcriptional regulation occur-
ring during ILC commitment. Currently, aLPs are the earliest
ILC progenitors described (Yu et al., 2014). This population con-
tains progenitors with a restricted potential and include the com-
mon helper innate lymphoid cell progenitor (CHILP) (Klose et al.,
2014) and the innate lymphoid cell precursor (ILCp). This
progenitor is characterized by expression of the transcription
factor PLZF (encoded by Zbtb16) and generate ILC1, ILC2,
and NKp46+ ILC3 but not NK or lymphoid tissue inducer (LTi)-
like cells (Constantinides et al., 2014). Recently, the early ILC.
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Identification of Innate Lymphoid
Precursors in the Bone Marrow
(A) Flow cytometric analysis of CLP and aLP
bone marrow cells from ID2gfp/gfp mice gated on
lin CD127+c-kitintSca-1int cells. Expression of
ID2, CD25, and c-kit is shown within the aLP
populations.
(B) Histograms showing the expression of PLZF
and TCF-1 in the indicated populations. Data are
representative of three similar experiments.progenitor (EILP), which is characterized by the expression of
TCF-1, was found to be able to give rise to NK cells and all known
ILC lineages (Yang et al., 2015). However, the EILP is distinct
from all other ILC precursors because it does not express
CD127.Whether EILP represent an alternate pathway for ILC dif-
ferentiation remains to be determined (Zook and Kee, 2016)
because it does not fit the current linear model of ILC differenti-
ation in which all ILC precursors express CD127 (IL-7R), which is
essential for development into mature cells in the periphery. We
therefore chose to focus our analyses on IL-7Ra-expressing
progenitors.
Using whole-genome analyses of in-vivo-derived cells, we
demonstrate that Tcf7 and Nfil3 are essential for the transition
of CLP to the aLP and the induction of an ILC-specific transcrip-
tional program. We identified several transcription factors that
have not been associated previously with ILC development.
These included Maf, Zbtb7b, and Ikzf2. Strikingly, Nfil3 was
required only transiently at the earliest stages of ILC develop-
ment, whereas Id2 drove ILC differentiation, at least in part,
through the repression of genes associated with stem cell main-
tenance and B and T cell differentiation. Collectively, we define
the transcriptional landscape of ILC precursors and provide
insight into the interplay of transcription factors, particularly the
hierarchical interactions, among Id2, Nfil3, and Tcf7 utilized by
progenitor cells to generate ILC populations.
RESULTS
Verification of Progenitors for Transcriptional Analyses
Initially, we confirmed the differentiation potential of several pro-
genitor stages for ILCs to ensure that our transcriptional analyses
would map accurately to the starting populations and the mature
differentiated cells they produced. The aLP (defined as linFlt3
c-kitintSca-1intCD127+a4b7
+ cells) is the earliest lymphoid pro-Celgenitor that lacks B and T cell potential
(Possot et al., 2011; Yu et al., 2014). Ana-
lyses of the aLP in bone marrow of ID2gfp
reporter mice using a gating strategy
similar to that reported previously showed
that this population included some CD25+
ILC2 progenitors (ILC2p) (Figure 1A; Hoyler
et al., 2012). The remaining aLP (CD25)
showed heterogeneous expression of
PLZF but uniformly expressed TCF-1 (Fig-
ure 1B) similar to the recently described
early ILC progenitors known as the EILP(Yang et al., 2015). Therefore, the aLP contains both the CHILP
(Klose et al., 2014) and PLZF+ ILCp (Constantinides et al.,
2014), as reported previously (Yu et al., 2014).
To confirm the lineage potential of the different progenitors
that we proposed to analyze using global gene profiling, we
transferred 1,000 purified, congenically marked (CD45.1+)
CLP (Kondo et al., 1997), a4b7
+ CLP (Ishizuka et al., 2016)
(a small population of cells that coexpressed both FLT3 and
a4b7), aLPs (that lacked CD25
+ cells), or ILC2ps (Hoyler et al.,
2012; Table S1; Figure S1) into sublethally irradiated Rag2/
gc
/ mice (CD45.2+). As expected, CLP gave rise to all
lymphoid populations (Figure S2A), whereas ILC2p only gener-
ated the ILC2 lineage (data not shown). Interestingly, the a4b7
+
CLP generated all ILC subsets but retained the capacity to
form a small fraction of T and B cells, similar to their recently
reported in vitro potential (Figure S3; Ishizuka et al., 2016). This
effect could be attributable to the lack of expression of Id2 at
this stage of development.
The aLP did not generate B cells or T cells but was able
to differentiate into all ILC subsets in the small intestine (Fig-
ure S2A). In the liver, the aLP efficiently gave rise to both
TRAILCD49b+ NK cells and TRAIL+CD49b ILC1 (Figure S2B),
a feature confirmed using our dual reporter ID2gfp3 eomesoder-
min (EOMES)mCherry mice to directly track these cells (Figures
S2C and S2D). Interestingly, in the spleen, only ID2+EOMES+
NK cells were generated from aLP, indicating that the micro-
environment likely plays an important role in supporting the
development of ILC1 (Figure S2D).
Transcriptional Dynamics of Innate Lymphoid Cell
Development
The precise molecular events that occur during ILC lineage
commitment are poorly understood. Using the aLP as defined
above without ILC2p contamination (Table S1; Figure S1), wel Reports 17, 436–447, October 4, 2016 437
sought to map the earliest transcriptional changes during ILC
commitment. Transcriptional analyses of small numbers of the
CLP and each ILC developmental stage (namely, the a4b7
+
CLP, the aLP, and ILC2p [CD25+]; Table S1) was performed
to map gene expression changes during ILC development.
Because each of these precursors represent extremely infre-
quent populations, we performed RNA sequencing (RNA-seq)
analysis on 100 cells using the recently described cell expression
by linear amplification and sequencing (CEL-seq) protocol (Ha-
shimshony et al., 2012).
Non-supervised hierarchical clustering and multi-dimensional
scaling (MDS) revealed that biological replicates clustered tightly
and did not overlap between the different purified populations,
confirming the quality of CEL-seq analysis, the purity of the sorts,
and that the gating strategy captured distinct populations (Fig-
ure 2A). We found that the a4b7
+ CLP clustered closely with the
CLP, implying a close developmental relationship between these
populations. We therefore focused our analysis on the transcrip-
tional changes that occurred during the transition between CLP,
aLP, and ILC2p. Overall, 462 genes were differentially regulated
between the CLP and aLP stage (Figure 2B). Among those, 251
transcripts were upregulated during the transition from CLP to
aLP, and 211 genes were downregulated. Genes differentially
regulated included the previously published key ILC commit-
ment factors Id2, Gata-3, Tox, and Tcf7. Importantly, we also
found genes such as Arginase-1 (encoded by Arg1), Lmo4,
Socs1, and Tox2, which were all upregulated during the transi-
tion from the CLP to aLP stage.
In the transition from the aLP toward the ILC2p, 97 genes
were upregulated, whereas 363 genes were downregulated,
indicating that a key requirement for the development of ILC2
subset was the repression of alternative lineage potential,
such as Sox4 (Schilham et al., 1996) or Myb (Allen et al., 1999),
because both genes have been implicated previously in B cell
and T cell development. In the transcripts showing expression
more than 4-fold higher than in the aLP, we found several
markers characteristic of ILC2, including Il1rl1, Il2ra, Ly6a,
CCR9, and Klrg1 as well as transcripts such as Socs2, Cysltr1,
Cish, Traf4, and Rnf128 (Figure 2C).
To monitor global transcriptional changes, we generated
a heatmap of gene sets for precursor-product transitions
that identified genes with significantly different expression in
two developmentally related populations (false discovery rate
[FDR] < 0.05) (Figure 2D). This allowed us to better visualize
the magnitude and number of transcripts induced or repressed
at each transition. The heatmap clearly revealed unique gene
signatures characteristic of each specific developmental stage.
To precisely identify the dominant transcriptional programs
present in the early innate lymphoid progenitors, we applied a
K-means clustering algorithm to the set of differentially regulated
genes that allows unsupervised pattern recognition (Figures 2E
and S4; Table S2). Thus, these analyses provide a rich resource
for discovering additional molecular actors in ILC development.
The first two clusters showed a down-modulation of genes.
Cluster 1 was associated with genes involved in early develop-
ment and differentiation, including the transcription factor
Sox4, the retinoid-inducible nuclear factor Cxxc5, and the core
binding factorCbfa2t3, which is able to interact with DNA-bound438 Cell Reports 17, 436–447, October 4, 2016transcription factors to facilitate transcriptional repression.
Genes in cluster 2 showed a strong downregulation from the
CLP stage to ILC progenitors and were associated with reduced
expression of T- and B cell-associated genes such asBlnk, Spib,
Rag1, and Lmo2. In contrast, cluster 3 included genes that were
upregulated after the CLP stage in aLP and generally maintained
or increased their expression in ILC2p. This cluster included
several genes encoding key transcriptional regulators of ILC
development, including Id2 and Gata-3, which have broad ef-
fects on multiple ILC subsets. Cluster 4 grouped genes that
are upregulated in ILC2p, such as Il1rl1 and Il2ra, together with
genes of unknown function in ILC2 biology, including Cish,
Socs2, or Tgfbr1. Cluster 5 included genes that are temporally
upregulated in aLP and contained genes such as Rorc, Rora,
Tcf7, Tox, and Eomes, all transcription factors that are associ-
ated with specific ILC subsets. The expression of genes that
are important for ILC subset specification suggests that priming
into the different ILC lineages already occurs at the aLP stage
and may explain why fewer than 10% of the ILC progenitors
give rise to all ILC subsets at a clonal level (Possot et al., 2011;
Yu et al., 2014). Support for this hypothesis comes from a recent
single-cell analysis of fetal liver-derived ILC precursors that
demonstrated mixed ILC1, ILC2, and ILC3 transcriptional pat-
terns (Ishizuka et al., 2016). Cluster 6 is similar to cluster 5 in
that genes were strongly downregulated during ILC2p commit-
ment but did not show such strong upregulation at the aLP
stage, similar to cluster 5. This cluster consisted of a number
of surface molecules such as Il18r1, Nkg7, Klrb1f, and Klrd1 or
altered intracellular trafficking and metabolism such as Galk2
andUnc119b. Collectively, these patterns identify discrete steps
in commitment to mature ILC lineages.
Identification of Early Regulators of Commitment in
Innate Lymphoid Precursors
To characterize the molecular profile of the aLP in more depth,
we focused our analysis on genes that were upregulated from
the transition of CLP to aLP and divided genes according to their
biological function defined in theMolecular Signatures Database
(MSigDB) (Figure 3A). First, we examined transcription factors
based on their role as key regulators of lineage commitment.
As expected, we found that genes encoding molecules with
previously assigned functions in ILC differentiation, such as
Id2, Tox, PLZF,Gata-3, and Tcf-7, were strongly modulated (Fig-
ure 3A). This expression was reflected in upregulation of protein
expression for TCF-1, PLZF (Figure 1A), LMO4, and GATA-3
(Figure 3B) and the sequential downregulation of factors such
as PU.1 and IRF8 as ILC progenitors undergo commitment (Fig-
ure 3B). Although PU.1 expression was downregulated in aLP
compared with CLP, all aLPs still expressed an intermediate
level of PU.1, a feature that could be used as an interesting
molecular marker to identify this precursor. Genes such as
Rxrg, Zbtb7b, Maf, Ikzf2, and Tox2 will require more extensive
investigation to identify their role in ILC differentiation (Figures
2D and 3A).
Among surface markers, we identified several immunoregula-
tory molecules, including the tumor necrosis factor (TNF) super-
family genes Tnfsf14 (encoding Light) Tnfsf25 (encoding Leaf),
CD160, Nt5e (CD73), ICOS, and CD226 (DNAM-1) and the
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Figure 3. Molecular Characterization of the aLP
(A) Heatmap representation of genes with at least 2-fold differences in expression pattern between CLP and aLP. Columns represent the indicated cell subsets in
seven to eight biological replicates. Gene sets are clustered according to their biological function based on the gene families of the MSigDB database.
(B and C) Histograms show intracellular expression of (B) GATA-3 and LMO4 (left) and GFP expression of IRF8gfp/+ and PU.1gfp/+ reporter mice (right) and (C)
surface expression of PD-1 and CD226 in the indicated populations. Data are representative of two independent experiments (n = 2–3 mice/experiment).
(D) Histograms showing intracellular expression of PLZF and GATA-3 in the PD1+ and PD1 fraction of the aLP. Data are representative of two independent
experiments (n = 2 mice/experiment).
(E) GSEA was performed to compare the CLP and aLP transcriptional profile with the KEGG and the MSigDB C5 GO.
(F) KEGG pathways are significantly enriched in aLP.inhibitory receptor PD-1 (programmed cell death protein 1) (Fig-
ures 3A and 3C). Flow cytometric analysis showed that CD226
was expressed uniformly on the aLP and that this was main-
tained on ILC2p, whereas the expression of PD-1 on aLP wasFigure 2. The Transcriptional Landscape of ILC Development
CEL-seq analysis was performed on highly purified precursors as defined in Figu
(A) MDS of the CEL-seq results obtained from the CLP (red), a4b7
+ CLP (purple)
sample, and samples are color-coded by population.
(B and C) Comparison of gene expression in (B) aLP versus CLP cells and in (C
upregulated in CLP (red), aLP (green), and ILC2p (blue).
(D) Heatmap showing the differentially expressed genes across ILC progenitor de
gene and subset. Genes are color-coded (see legend) to display relative gene ex
(E) K-means clustering into six clusters based on expression pattern during early
centered, gray lines) and cluster centroids (black line) for each cluster.
440 Cell Reports 17, 436–447, October 4, 2016heterogeneous and downregulated on ILC2p (Figure 3C).
Because PD-1 was expressed only in a fraction of the aLP, we
wondered whether this marker could be used to discriminate
precursor subsets known to be contained in the aLP, such asres 1 and S2.
, aLP (green), and ILC2p (blue) populations. Each point represents a different
) ILC2p versus aLP in smear plots. Colored dots indicate genes significantly
velopmental stages. Data were row-normalized and hierarchically clustered by
pression.
ILC differentiation. Shown is the expression of genes (log2-transformed mean-
AB
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Figure 4. Development of ILC Precursors
Gradually Depends on Nfil3, Tcf7, and Id2
(A) Counts per million mapped reads for Nfil3, Tcf7,
and Id2 in CLP, a4b7
+ CLP, aLP, and ILC2p are
shown (mean ± SD).
(B) Flow cytometric analyses of lineage bone
marrow cells from wild-type (WT), Id2fl/flVavCre+/T,
Tcf7/, and Nfil3/ mice. The profiles show
the frequency of each progenitor subset gated on
live lin CD127+ cells. The data show one of two
representative experiments.
(C) Total cell number of the indicated populations
isolated from wild-type, Id2fl/flVavCre+/T, Tcf7/,
and Nfil3/ mice. The data show the mean ± SD
pooled from two independent experiments (n = 4).the PLZF+ ILCp (Constantinides et al., 2014; Yu et al., 2014).
Interestingly, the PD1+ fraction of the aLP contained PLZF-
and Gata3-expressing cells, indicating that PD-1 specifically
identify the ILCp (Figure 3D). Despite this distinct expression
pattern of PD-1, however, analysis of Pdcd1/ mice demon-
strated that PD-1 expression is not essential for the formation
of the aLP and does not affect the development of mature ILC
at steady state (Figure S5). Thus, PD-1 and CD226 representCeimportant markers for the identification of
aLP that will allow the isolation of these
cells without the use of reporter mice for
ID2 or PLZF.
To gain further insight into the biological
processes controlled by differential gene
expression between the CLP and aLP,
gene set enrichment analysis (GSEA) was
performed (Figures 3E and 3F). We used
all pathways in the Kyoto Encyclopedia
of Genes and Genomes (KEGG) as well
as gene ontology (GO) from the MSigDB
C5 database. Both analyses revealed a
significant enrichment for cytokine and
chemokine-mediated signaling pathways
and molecules involved in immune protec-
tion and defense (Figures 3E and 3F).
These analyses indicate that the aLP dif-
fers significantly from the CLP and has
already started to acquire a profile consis-
tent with differentiation toward effector
lineages.
Understanding Transcriptional
Initiation in ILC Progenitors
Although ID2, NFIL3, and TCF-1 have all
been identified as key regulators of early
ILC and NK cell differentiation, the kinetic
of expression and how these transcription
factors are regulated during ILC commit-
ment is unknown. Our analysis revealed
that the expression of these factors is
tightly regulated during ILC development
(Figure 4A). None of these factors were ex-pressed in CLP; however, Nfil3 was already induced in the a4b7-
expressing CLP fraction and was subsequently downregulated
in latter progenitors, supporting the notion that early induction
of Nfil3 is necessary for ILC development (Seillet et al., 2014b).
Tcf7 and Id2 were both strongly induced in the aLP, whereas
ID2 expression was maintained in ILC2p, but Tcf7 expression
was downregulated (Figure 4A). These data suggest that each
of these factors play an important role at distinct checkpointsll Reports 17, 436–447, October 4, 2016 441
in ILC development. We therefore performed a detailed analysis
of the early progenitor stages in the bonemarrow of NFIL3-, ID2-,
and TCF-1-deficient mice (Figure 4B).
Consistent with lack of mRNA expression of Nfil3, Id2, and
Tcf7 at the CLP stage, the formation of CLP was not affected
when these transcription factors were deleted (Figure 4B). This
was not the case for the a4b7
+ CLPs, which were significantly
reduced in Nfil3/ mice, mirroring the increased Nfil3 observed
in our analyses (Figures 4A and 4B). We observed a gradual loss
of ILC progenitors in the different knockout mice with defects
in Nfil3/ > Tcf7/ > Id2/, suggesting different temporal
requirements for these transcription factors as they transition
between each developmental stages (Figure 4C). Similar defects
were also observed in mature cells in chimeric mice reconsti-
tuted with transcription factor-deficient bone marrow (Figure S6)
indicating that the observed effects were cell-intrinsic. Unex-
pectedly, the aLP was less affected in Id2fl/flVavCre+/T mice
compared with Tcf7/ and Nfil3/ mice, indicating that ID2 is
not required for the formation of the aLP but acts downstream
of this stage (Figure 4C).
Because Nfil3 was only transiently expressed in ILC progeni-
tors, we questioned whether NFIL3 was required for the subse-
quent maintenance of the ILC differentiation program.We gener-
ated Nfil3fl/flId2-CreERT2+/T mice to allow spatiotemporal
deletion of NFIL3 in ID2-expressing cells. aLPs were purified
from Nfil3fl/flId2-CreERT2+/T mice and subsequently cultured
on OP9 stromal cells in the presence of interleukin-15 (IL-15) or
IL-33 and 4-hydroxytamoxifen (4-OHT) or ethanol (control) to
drive the differentiation of either ILC1/NK cells or ILC2. Surpris-
ingly, deletion of NFIL3 in ID2+ cells had no apparent effect on
the development of the ILC under either ILC1 or ILC2 conditions
(Figures 5A and 5B). Both the frequency and the number of ILC1
or ILC2 generated in vitro were similar in both the 4-OH-treated
and control cultures (Figures 5A–5C). Deletion of Nfil3 in these
cells, however, was complete (Figure 5D). We next assessed
whether mature ILC populations would be maintained in vivo in
the absence of Nfil3 following induction of ID2. Strikingly, the
loss of Nfil3 in these mice did not alter the number of mature
ILC1, 2, and 3 in the mesenteric lymph nodes (Figure 5E) or small
intestine (data not shown) or the expression of Gata-3 or Rorgt,
which are important to maintain the identity of ILC2 and ILC3,
respectively. Furthermore, NK cells and ILC1 were unaffected
in the liver (Figure 5E) and the spleen (data not shown), indicating
that ablation of NFIL3 after ID2 induction does not affect their for-
mation ormaintenance. Because the onset of ID2 expression oc-
curs very early in ILC development, this implies that NFIL3 only
acts during the transition from the CLP to the aLP. Similar to
our findings in in vitro cultures, in vivo treatment with tamoxifen
efficiently induced deletion ofNfil3 specifically in ID2-expressing
cells, whereas we could not detect any deletion in ID2-negative
cells such as naive T cells (Figure 5F). Thus, NFIL3 is a key factor
for the formation of the a4b7
+ CLP and the aLP but is dispensable
after the onset of ID2 expression.
Because the induction of Nfil3, Id2, and Tcf7 represents the
first molecular steps for ILC development, we endeavored to
comprehensively profile the genes regulated by these transcrip-
tion factors in aLP at a genome-wide level. Although theCEL-seq
protocol allows transcriptomic analysis on a very small amount442 Cell Reports 17, 436–447, October 4, 2016of RNA, the defect in NFIL3-deficient mice was so profound
that it precluded the generation of libraries of sufficient quality
for further analyses. Therefore, we focused our analysis on the
remaining aLP found in the ID2- and TCF-1-deficient mice (Fig-
ures 6A and 6B). Using this approach, we identified 127 differen-
tially regulated genes in Id2/ aLP and 110 genes in Tcf7/ aLP
compared with their wild-type counterparts. Interestingly, few
shared genes were found to be differentially regulated between
ID2- and TCF-1-deficient cells, suggesting that these two tran-
scription factors control distinct transcriptional programs during
ILC development (Figures 6C and 6D). The requirement for these
two transcription factors for the full expression of the signature
genes of the aLP was highlighted by the significant downmodu-
lation of the expression of the majority of genes found in the aLP
signature (Figures 6E and 6F). Several genes identified in this
signature were downregulated in the absence of ID2, including
Tox, Gata-3, Arg1, and Lmo4, suggesting that these factors
are within an ID2-regulated pathway and that ID2 is required
for their continuous expression. Loss of ID2 also correlated
with an increase in many genes normally repressed after transi-
tion from the CLP (Figure 2). These included Gfi1b, Tal1, Lmo2,
Gata-2, and Hhex, which are known to have important functions
in hematopoietic progenitors (Figure 6A; Table S3). Gene set
enrichment analysis using published cluster genes associated
with stem cell or pro-B cell signatures (Mingueneau et al.,
2013; Revilla-I-Domingo et al., 2012) revealed that genes
repressed by ID2—i.e., those upregulated in ID2-deficient aLP
in comparison with wild-type aLP—were enriched for hemato-
poietic progenitor cell or signature genes (Figure 6E). Notably,
Tal1,Gfi1b, and Bcl11a are already known to be targets of E pro-
tein regulation (Le´cuyer et al., 2007; Lin et al., 2010; Xu and Kee,
2007). Thus, ID2 induction is accompanied by a major regulatory
shift with broad repression of progenitor cell transcription factor
genes to foster ILC lineage commitment and induce critical reg-
ulators such as Tox and Gata-3 (Figure 6A). Similar to the loss of
ID2, in the absence of Tcf7, Hhex and Lmo2, two genes known
to be involved in stem cell function, were upregulated in addition
to genes linked to the B cell program, such as Spib, Irf8, or
Ly6d. Gene set analysis confirmed the enrichment of unregu-
lated genes associated with a pro-B cell signature (Figure 6F).
In contrast, Bcl11b was downregulated only in Tcf7/ aLP,
consistent with a loss of ILC2 in Tcf7/ mice (Mielke et al.,
2013). This suggests that Tcf7 expression actively represses
gene expression programs to allow differentiation of ILC.
DISCUSSION
The recent identification of committed ILC progenitors in the
bone marrow has opened new opportunities to understand
how the innate lymphoid lineage emerges during hematopoiesis.
However, the rarity of these precursors in vivo has complicated
the analysis of the transcriptome of these cells. We used CEL-
seq technology to perform full RNA sequencing on different
ILC populations and identify transcriptional transitions associ-
ated with the lineage progression of innate lymphocytes.
To identify the very first transcriptional changes occurring dur-
ing ILC specification, we performed a comprehensive transcrip-
tional analysis of various progenitor stages using RNA-seq,
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Figure 5. Transient Expression of Nfil3 Is Sufficient to Induce Commitment to the ILC Lineage
(A andB) Purified aLP fromNfil3+/+Id2CreERT2+/T andNfil3fl/flId2CreERT2+/Tmicewere culturedwith IL-7, stem cell factor (SCF(, and either (A) IL-15 or (B) IL-33 to
promote their differentiation into ILC1/NK cells or ILC2, respectively. Cells were cultured for 10 days in the presence or absence of 4-OHT as indicated.
Expression of NK1.1, CD49a, RORgt, andGATA-3was analyzed by flow cytometry to track differentiation of NK cells, ILC1, ILC2, and ILC3. The profiles showone
representative of two experiments with similar findings.
(C) Total number of ILC1 and ILC2 recovered after 4-OH treatment ofNfil3+/+Id2CreERT2+/T andNfil3fl/flId2CreERT2+/T cells in vitro. The data show themean ±SD
pooled from two independent experiments (n = 4).
(D) Deletion of the Nfil3 allele was analyzed using PCR on purified NK cells cultured from Nfil3fl/flId2CreERT2+/T or Nfil3+/+Id2CreERT2+/T cells with or without
treatment with 4-OHT. Ladder, 10 kb.
(E and F) Nfil3fl/flId2CreERT2+/T and control Nfil3+/+Id2CreERT2+/T mice were treated with tamoxifen for 10 days, and ILC1, 2, and 3 were analyzed in the
mesenteric lymph nodes (mLN) (left) and liver (right).
(E) Histograms show the mean frequency of cells ± SD of data pooled from two independent experiments (n = 6 mice/genotype). Profiles are gated on
CD45+CD19CD3 cells.
(F) Deletion of the Nfil3 allele was analyzed using PCR on purified NK cells or T cells from mice analyzed in (E). Ladder, 10 kb.
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Figure 6. Id2 and Tcf7 Regulate Distinct
Transcriptional Programs to Repress Stem
Cell, B Cell, and T Cell Potential
(A and B) Comparison of gene expression between
aLP from (A) WT and Id2fl/flVavCre+/T (Id2/) cells
and in (B) WT and Tcf7/ mice shown in smear
plots.
(C and D) Venn diagrams showing unique and
overlapping genes. Shown are (C) upregulated and
(D) downregulated genes in Id2/ and Tcf7/ aLP.
Complete lists of genes in each Venn category are
listed in Table S3.
(E and F) Gene set enrichment analysis of genes
(shaded rectangles,horizontally ranked by moder-
ated t statistic) upregulated (pink, t > 1), down-
regulated (blue, t <1), or not altered (gray) in Id2/
and Tcf7/ aLP relative to their expression in
wild-type aLP (vertical black lines indicate genes
encoding for the indicated gene sets).permitting us to map the developmental changes of the bone
marrow-derived progenitors during differentiation. We identified
a specific ILC transcriptional program allowing us to generate a
more accurate definition of the different stages of ILC commit-
ment and specification. The transition between the aLP and
ILC2p was associated with upregulation of Il1rl1, Il2ra, Ly6a,
CCR9, andKlrg1 together with several transcripts that may regu-
late ILC2 function or development. These included Socs2,
Cysltr1, Cish, Traf4, and Rnf128 (also known as GRAIL) (Fig-
ure 3C). Cysltr1 encodes cysteinyl leukotriene receptor 1, which
triggers the production of cysteinyl leukotrienes. These factors
are critical for the induction of Th2 immunity to allergens in the
lung (Barrett et al., 2011), and one could postulate that they
represent another important level for regulating ILC2 function.
A second gene, Rnf128, is an ubiquitin-protein ligase (E3) and
an important gatekeeper of T cell responsiveness, tolerance in-444 Cell Reports 17, 436–447, October 4, 2016duction, and maintenance (Nurieva et al.,
2010). We also identified differential
expression of Zbtb7b (also known as
Thpok), Runx3, and Ets1. Interestingly
ETS-1 has been described recently to pro-
mote the development of ILC2p in the bone
marrow (Zook et al., 2016).
Our study also revealed other surface
markers to identify the aLP in adult bone
marrow. Importantly, we identified PD-1
as a marker of the PLZF+ ILCp in the
bone marrow. This is very interesting
because, until now, these cells could only
be identified using reporter mice. Our
data suggest that the induction of PD-1
on the aLP marks the separation between
the ILC and the NK cell lineage because
PLZF+ ILCps have lost the NK cell poten-
tial, whereas the aLP can generate both
lineages (Constantinides et al., 2014; Yu
et al., 2014). Interestingly, these markers
are important inhibitory receptors oflymphocyte activation. Because PD1 and CD226 function act
as a ‘‘rheostat’’ to modulate lymphocyte responses, it is
intriguing that these receptors are also expressed on the ILC
progenitor. Although we did not find any impairment of ILC
development in Pdcd1/ mice, more investigation will be
required to assess the role of these receptors in ILC function.
A key step in defining both the commitment and subsequent
specification of ILC depends on NFIL3 and ID2 because these
transcription factors have been established as critical regulators
of ILC development. Despite this, the exact temporal require-
ment for these two factors and how they interact have not
been fully elucidated. NFIL3 expression is induced by IL-7 orig-
inating from mesenchymal cells and is essential for the develop-
ment of ILC progenitors prior to commitment (Seillet et al.,
2014b; Xu et al., 2015). Accordingly, ablation of NFIL3 results
in the loss of both ID2+ and PLZF+ ILC progenitors, indicating
that it exerts its action through the direct binding of NFIL3 at
the ID2 locus (Xu et al., 2015). Nevertheless, ID2 expression is
not completely lost when NFIL3 is removed (Klose et al., 2014;
Robinette et al., 2015; Seillet et al., 2014a). In our studies,
Nfil3-deficient bone marrow exhibited the most profound
defect in progenitor development, supporting previous findings.
Surprisingly, we found that the loss of NFIL3 function in cells
expressing ID2 did not significantly affect the subsequent devel-
opment of ILC subsets. This result is concordant with the obser-
vation that deletion of NFIL3 using Rorgt-Cre did not significantly
interrupt subsequent ILC development (Xu et al., 2015), and
the lack of a requirement for NFIL3 to maintain mature NK cells,
ILC1, and ILC3, as reported previously (Firth et al., 2013). Our
findings extend these observations and demonstrate that the
downstream role of ID2 is also independent of NFIL3. In addition,
it reinforces the notion that transient expression of transcrip-
tional regulators such as NFIL3 in ILC progenitors is necessary
and sufficient to establish lineage commitment but is subse-
quently dispensable in controlling ILC development into mature
cells.
Collectively, our data establish a genome-wide transcriptional
blueprint of the different ILC progenitors and uncover potentially
important transcriptional regulators that are likely to reveal key
insights into ILC development and interactions with other im-
mune cells in the tissue.
EXPERIMENTAL PROCEDURES
Mice
Tcf7/ (Verbeek et al., 1995), ID2gfp (Jackson et al., 2011), Id2fl/fl (Masson
et al., 2013), VavCre+/T (Croker et al., 2004), Nfil3/ (Gascoyne et al.,
2009), Nfil3fl/fl (Motomura et al., 2011), Rag2/gc
/ (Garcia et al., 1999),
B6.129S (Cg)-Id2tm1.1 (cre/ERT2)Blh/ZhuJ (Id2-CreERT2) (Rawlins et al., 2009),
CD45.1+EomesmCherry (Kara et al., 2015), Pcdc1/ (Keir et al., 2007), Irf8egfp
(Wang et al., 2014), and PU.1gfp (Nutt et al., 2005) mice have been described
previously. C57BL/6, B6.SJL-Ptprca Pep3b/BoyJ (Ly5.1+/+, CD45.1+/+) and
Ly5.1+ 3 Ly5.2+ (F1) mice were bred and maintained in-house. Id2-CreERT2
mice were crossed to Nfil3fl/fl mice to generate Nfil3fl/flId2-CreERT2+/T mice
(hereafter designated Nfil3fl/flId2ERT2+/T), and VavCre+/T mice were crossed
to Id2fl/fl mice to generate Id2fl/flVavCre+/T mice lacking ID2 in the hematopoi-
etic compartment. Estrogen receptor-mediated deletion of loxP-flanked al-
leles was triggered by the administration of tamoxifen (0.2 mg/g body weight)
by oral gavage every 2 days for 10 days. For in vitro experiments, cells were
treated with 200 nM 4-hydroxytamoxifen (Sigma-Aldrich). Mice were used at
8–12 weeks of age unless otherwise stated. All animals were maintained and
bred under specific pathogen-free conditions and used in accordance with
the guidelines of theWalter and Eliza Hall Institute of Medical Research Animal
Ethics Committee.
Isolation and Analyses of Intestinal Lymphocytes
Intestinal lamina propria lymphocytes were isolated from the lamina propria
following digestion with Collagenase III (1 mg/mL, Worthington Biochemical),
DNase I (200 mg/mL, Roche), and dispase (4 U/mL, Sigma) for 45 min at
37C. Single-cell suspensions were stained with the following antibodies:
TCRb (H57-597) from BioLegend; CD19 (ID3), CD3 (145-2C11), ICOS
(C398.4A), NKp46 (29A1.4), NK1.1 (PK136), CD117 (2B8), CD127 (A7R34),
Sca-1 (D7), and ST2 (RMST2-2) from eBioscience; and CD45.1 (A20)
CD45.2 (104), CD90.2 (30-H12), and CD49a (Ha31/8) from BD Biosciences.
Intracellular staining was performed using the transcription factor staining
buffer set (eBioscience) and antibodies against GATA-3 (TWAJ), Rorgt
(AFKJS-9), and EOMES (Dan11mag) (eBioscience). LMO4was identified using
rabbit anti-mouse LMO4 (Abcam, Ab133010) followed by fluorescein isothio-
cyanate (FITC)-conjugated donkey anti-rabbit (Jackson ImmunoResearch).Cells were analyzed using a FACS Fortessa (BD Biosciences), and FlowJo
software was used for analysis.
Isolation and Analysis of Bone Marrow Progenitors
BM cells were isolated from long bones and sternum, filtered through 70-mm
cell strainers, and blocked with a-CD16/32 (2.4G2) followed by biotinylated
anti-IL-7R (CD127) antibody. Cell suspensions were washed and incubated
with a-biotin magnetic microbeads (Miltenyi Biotec) and enriched for the
IL-7R/biotin binding fraction. These cells were then stained for c-kit (2B8),
CD127 (A7R34), Sca-1 (D7), Flt3 (A2F10), a4b7 integrin (DATK32), CD25
(PC61.5), and streptavidin. Lineage-positive cells (Lin+) were excluded from
analyses by staining with antibodies for CD3ε (145-2C11), B220 (RA3-6B2),
CD11b (M1/70), Gr1 (RB6-8C5), TER119, CD49b (DX5), NKp46 (29A1.4),
F4/80 (BM8), CD122 (TM-b1), TCRb (H57-597), and NK1.1 (PK136). Flow
cytometric sorting was performed on a FACS Aria (BD Biosciences).
Mixed Fetal Liver Chimeras
Ly5.2+Ly5.1+ wild-type mice were lethally irradiated (23 550 rads) and recon-
stituted with a mixture (ratio of 1:6) of wild-type (Ly5.1+) and Tcf7/ (Ly5.2+)
fetal liver cells. Mice were allowed to reconstitute their hematopoietic system
for 8 weeks before use.
Adoptive Transfer of ILC Progenitors
Different precursor populations were purified fromCD45.1+, CD45.1+Id2gfp/gfp,
or CD45.1+EOMESmCherrymice as described above. 0.6-13 103 highly purified
cells were transplanted into sublethally irradiated (450 rads) Rag2/gc
/
recipients by lateral tail vein injection. Recipients were analyzed 7–10 weeks
after transplant.
CEL-Seq Primer Design
RT primers were designed with an anchored polyT, a unique bar code, the 50
Illumina adaptor (as used in the Illumina small RNA kit), and a T7 promoter. The
bar codes were eight base pairs (bp) long and designed in groups of four
so that the first five nucleotides will have equal representation of all four nucle-
otides to allow for template generation and crosstalk corrections based on
the first four nucleotides read in the Illumina platform. The bar codes were
designed so that each pair was different by at least two nucleotides so that
a single sequencing error will not produce the wrong bar code.
Library Generation Using CEL-Seq
100 cells of each population were directly sorted into 384-well plates. Each
well contained lysis buffer with a unique primer, ERCC spike-in control, and
SuperaseIN RNA inhibitor. CEL-seq libraries were constructed using a proto-
col described earlier (Hashimshony et al., 2012; Liao et al., 2013). Briefly, dou-
ble-stranded cDNA libraries were prepared and later pooled together for an
in vitro transcription reaction using the Ambion MessageAmp II aRNA amplifi-
cation kit. Illumina libraries were built following the manufacturer’s instructions
using the Illumina TruSeq small RNA sample prep kit and sequenced on the
Illumina MiSeq and NextSeq platform according to standard protocols for
100-bp single-end sequencing.
CEL-Seq Data Analysis
For MiSeq and NextSeq sequencing data, the base calling and quality scoring
were performed using Illumina’s real-time analysis software (versions 1.18.54
and 2.4.6, respectively). FASTQ file generation and de-multiplexing was car-
ried out using MiSeq reporter software (version 2.4.60) and bcl2fastq conver-
sion software (version 2.15.0.4). Reads from the FASTQ files were aligned to
the mouse genome (mm10) using Rsubread (version 1.18.0) and summarized
at the gene level using the featureCounts procedure (Liao et al., 2014). Subse-
quent analysis was carried out using the edgeR Bioconductor package. The
counts were transformed into counts per million (CPM) to standardize for dif-
ferences in library size, and filtering was carried out to remove genes that were
not expressed in any sample. One outlier sample that did not cluster well with
other samples of the same type was removed based on visual inspection of the
MDS plots. Data were TMM-normalized, and generalized linear models were
fitted using glmFit and the associated pipeline from edgeR (version 3.10.2).
Genes were ranked for differential expression using likelihood ratio tests,Cell Reports 17, 436–447, October 4, 2016 445
and significant genes (FDR < 0.05) were clustered using the K-means algo-
rithm from the stats package in R with k = 6 clusters on normalized expression
levels to produce clustered expression profiles. Heatmap displays were gener-
ated using the log2 counts per million with batch effects removed using remov-
eBatchEffect from the limma (Ritchie et al., 2015) package and the heatmap.2
function from the gplots (Warnes et al., 2015) package with row scaling.
Statistical Analysis
A two-tailed Student’s t test was performed using Prism (GraphPad) to deter-
mine statistical significance.
Pathway Analysis and GSEA
The GSEA method is available at http://www.broad.mit.edu/ (Subramanian
et al., 2007). To test whether gene sets were enriched in pairwise comparisons
between CLP and aLP, nominal p values were calculated as well as FDR
(q value) based on 1,000 random permutations between gene sets. Results
were considered significant when p < 0.05 and q < 0.25. Signature gene
sets were derived from Mingueneau et al. (2013) and Revilla-I-Domingo et al.
(2012), and rotation gene set testing was performed using the mroast function
in edgeR.
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